Pneumococcal Transmission and Disease In Silico: A Microsimulation Model of the Indirect Effects of Vaccination

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Nurhonen, Markku ^a   Cheng, Allen C ^b   Auranen, Kari ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM CARRIER; CHILD; CLINICAL EFFECTIVENESS; COMPUTER MODEL; DEVELOPED COUNTRY; DISEASE PREDISPOSITION; DISEASE SIMULATION; FINLAND; HERD IMMUNITY; HUMAN; INCIDENCE; MASS SCREENING; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PREVALENCE; PUBLIC HEALTH; SCHOOL CHILD; SECONDARY INFECTION; SEROTYPE; VACCINATION;

ADOLESCENT; AGE FACTORS; CARRIER STATE; CHILD; CHILD, PRESCHOOL; COMPUTER SIMULATION; FINLAND; HUMANS; IMMUNITY, HERD; INFANT; MODELS, BIOLOGICAL; MODELS, ECONOMIC; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 84873537250     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056079     Document Type: Article

References (41)

1. Weiser JN, (2010) The pneumococcus: Why a commensal misbehaves. J Mol Med (Berl) 88 (2) (): 97-102 10.1007/s00109-009-0557-x.
2. Calix JJ, Nahm MH, (2010) A new pneumococcal serotype, 11E, has a variably inactivated wcjE gene. J Infect Dis 202 (1) (): 29-38 10.1086/653123.
3. Hanage WP, Kaijalainen TH, Syrjanen RK, Auranen K, Leinonen M, et al. (2005) Invasiveness of serotypes and clones of streptococcus pneumoniae among children in finland. Infect Immun 73 (1) (): 431-435 10.1128/IAI.73.1.431-435.2005.
4. Brueggemann AB, Peto TE, Crook DW, Butler JC, Kristinsson KG, et al. (2004) Temporal and geographic stability of the serogroup-specific invasive disease potential of streptococcus pneumoniae in children. J Infect Dis 190 (7) (): 1203-1211 10.1086/423820.
5. Levine OS, Knoll MD, Jones A, Walker DG, Risko N, et al. (2010) Global status of haemophilus influenzae type b and pneumococcal conjugate vaccines: Evidence, policies, and introductions. Curr Opin Infect Dis 23 (3) (): 236-241 10.1097/QCO.0b013e328338c135.
6. Pavia M, Bianco A, Nobile CG, Marinelli P, Angelillo IF, (2009) Efficacy of pneumococcal vaccination in children younger than 24 months: A meta-analysis. Pediatrics 123 (6) (): e1103-10 10.1542/peds.2008-3422.
7. Obaro SK, Adegbola RA, Banya WA, Greenwood BM, (1996) Carriage of pneumococci after pneumococcal vaccination. Lancet 348 (9022) (): 271-272.
8. Mbelle N, Huebner RE, Wasas AD, Kimura A, Chang I, et al. (1999) Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis 180 (4) (): 1171-1176 10.1086/315009.
9. De Wals P, Black S, Borrow R, Pearce D, (2009) Modeling the impact of a new vaccine on pneumococcal and nontypable haemophilus influenzae diseases: A new simulation model. Clin Ther 31 (10) (): 2152-2169 10.1016/j.clinthera.2009.10.014.
10. Beutels P, Thiry N, Van Damme P, (2007) Convincing or confusing? economic evaluations of childhood pneumococcal conjugate vaccination-a review (2002-2006). Vaccine 25 (8) (): 1355-1367 10.1016/j.vaccine.2006.10.034.
11. Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, et al. (2010) Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 201 (1) (): 32-41 10.1086/648593.
12. Miller E, Andrews NJ, Waight PA, Slack MP, George RC, (2011) Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in england and wales: An observational cohort study. Lancet Infect Dis 10.1016/S1473-3099(11)70090-1.
13. Weinberger DM, Malley R, Lipsitch M, (2011) Serotype replacement in disease after pneumococcal vaccination. Lancet 10.1016/S0140-6736(10)62225-8.
14. Hanage WP, Finkelstein JA, Huang SS, Pelton SI, Stevenson AE, et al. (2010) Evidence that pneumococcal serotype replacement in massachusetts following conjugate vaccination is now complete. Epidemics 2 (2) (): 80-84 10.1016/j.epidem.2010.03.005.
15. Vestrheim DF, Hoiby EA, Aaberge IS, Caugant DA, (2010) Impact of a pneumococcal conjugate vaccination program on carriage among children in norway. Clin Vaccine Immunol 17 (3) (): 325-334 10.1128/CVI.00435-09.
16. Lipsitch M, (1997) Vaccination against colonizing bacteria with multiple serotypes. Proc Natl Acad Sci U S A 94 (12) (): 6571-6576.
17. Weinberger DM, Trzcinski K, Lu YJ, Bogaert D, Brandes A, et al. (2009) Pneumococcal capsular polysaccharide structure predicts serotype prevalence. PLoS Pathog 5 (6) (): e1000476 10.1371/journal.ppat.1000476.
18. Melegaro A, Choi YH, George R, Edmunds WJ, Miller E, et al. (2010) Dynamic models of pneumococcal carriage and the impact of the heptavalent pneumococcal conjugate vaccine on invasive pneumococcal disease. BMC Infect Dis 10: 90 10.1186/1471-2334-10-90.
19. Choi YH, Jit M, Gay N, Andrews N, Waight PA, et al. (2011) 7-valent pneumococcal conjugate vaccination in england and wales: Is it still beneficial despite high levels of serotype replacement? PLoS One 6 (10) (): e26190 10.1371/journal.pone.0026190.
20. Karlsson D, (2011) Probabilistic network modelling of the impact of penicillin consumption on spread of pneumococci. Epidemiol Infect 139 (9) (): 1351-1360 10.1017/S0950268810002773.
21. Temime L, Boelle PY, Opatowski L, Guillemot D, (2008) Impact of capsular switch on invasive pneumococcal disease incidence in a vaccinated population. PLoS One 3 (9) (): e3244 10.1371/journal.pone.0003244.
22. Van Effelterre T, Moore MR, Fierens F, Whitney CG, White L, et al. (2010) A dynamic model of pneumococcal infection in the united states: Implications for prevention through vaccination. Vaccine 28 (21) (): 3650-3660 10.1016/j.vaccine.2010.03.030.
23. Cobey S, Lipsitch M, (2012) Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes. Science 335 (6074) (): 1376-1380 10.1126/science.1215947.
24. Talbird SE, Ismaila AS, Taylor TN, (2010) A steady-state, population-based model to estimate the direct and indirect effects of pneumococcal vaccines. Vaccine 28 Suppl 6: G3-13 10.1016/j.vaccine.2010.06.013.
25. Syrjanen RK, Kilpi TM, Kaijalainen TH, Herva EE, Takala AK, (2001) Nasopharyngeal carriage of streptococcus pneumoniae in finnish children younger than 2 years old. J Infect Dis 184 (4) (): 451-459 10.1086/322048.
26. Leino T, Hoti F, Syrjanen R, Tanskanen A, Auranen K, (2008) Clustering of serotypes in a longitudinal study of streptococcus pneumoniae carriage in three day care centres. BMC Infect Dis 8: 173 10.1186/1471-2334-8-173.
27. Palmu A, Kaijalainen T, Verho J, Herva E, Mäkelä PH,et al. (2002) Long-term efficacy of the sevenvalent PncCRM vaccine on nasopharyngeal carriage. 3th International Symposium on Pneumococci and Pneumococcal Diseases (ISSPD) Anchorage, Alaska.
28. Auranen K, Eichner M, Leino T, Takala AK, Makela PH, et al. (2004) Modelling transmission, immunity and disease of haemophilus influenzae type b in a structured population. Epidemiol Infect 132 (5) (): 947-957.
29. Melegaro A, Choi Y, Pebody R, Gay N, (2007) Pneumococcal carriage in united kingdom families: Estimating serotype-specific transmission parameters from longitudinal data. Am J Epidemiol 166 (2) (): 228-235 10.1093/aje/kwm076.
30. Hoti F, Erasto P, Leino T, Auranen K, (2009) Outbreaks of streptococcus pneumoniae carriage in day care cohorts in finland- implications for elimination of transmission. BMC Infect Dis 9: 102 10.1186/1471-2334-9-102.
31. Wallinga J, van Boven M, Lipsitch M, (2010) Optimizing infectious disease interventions during an emerging epidemic. Proc Natl Acad Sci U S A 107 (2) (): 923-928 10.1073/pnas.0908491107.
32. Iozzi F, Trusiano F, Chinazzi M, Billari FC, Zagheni E, et al. (2010) Little italy: An agent-based approach to the estimation of contact patterns- fitting predicted matrices to serological data. PLoS Comput Biol 6 (12) (): e1001021 10.1371/journal.pcbi.1001021.
33. Garnett GP, Cousens S, Hallett TB, Steketee R, Walker N, (2011) Mathematical models in the evaluation of health programmes. Lancet 378 (9790) (): 515-525 10.1016/S0140-6736(10)61505-X.
34. Sleeman KL, Griffiths D, Shackley F, Diggle L, Gupta S, et al. (2006) Capsular serotype-specific attack rates and duration of carriage of streptococcus pneumoniae in a population of children. J Infect Dis 194 (5) (): 682-688 10.1086/505710.
35. Halloran M.E., Longini I.M., Struchiner C.J (2010) Design and analysis of vaccine studies.: Springer.
36. Flasche S, Van Hoek AJ, Sheasby E, Waight P, Andrews N, et al. (2011) Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in england: A cross-sectional study. PLoS Med 8 (4) (): e1001017 10.1371/journal.pmed.1001017; 10.1371/journal.pmed.1001017.
37. Spijkerman J, van Gils EJ, Veenhoven RH, Hak E, Yzerman EP, et al. (2011) Carriage of streptococcus pneumoniae 3 years after start of vaccination program, the netherlands. Emerg Infect Dis 17 (4) (): 584-591 10.3201/eid1704.101115.
38. Mossong J, Hens N, Jit M, Beutels P, Auranen K, et al. (2008) Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 5 (3) (): e74 10.1371/journal.pmed.0050074.
39. Rinta-Kokko H, Dagan R, Givon-Lavi N, Auranen K, (2009) Estimation of vaccine efficacy against acquisition of pneumococcal carriage. Vaccine 27 (29) (): 3831-3837 10.1016/j.vaccine.2009.04.009.
40. Park IH, Moore MR, Treanor JJ, Pelton SI, Pilishvili T, et al. (2008) Differential effects of pneumococcal vaccines against serotypes 6A and 6C. J Infect Dis 198 (12) (): 1818-1822 10.1086/593339.
41. Lipsitch M, O'Neill K, Cordy D, Bugalter B, Trzcinski K, et al. (2007) Strain characteristics of streptococcus pneumoniae carriage and invasive disease isolates during a cluster-randomized clinical trial of the 7-valent pneumococcal conjugate vaccine. J Infect Dis 196 (8) (): 1221-1227 10.1086/521831.